Blackstone Group and Carlyle Group along with privately owned company Hellman & Friedman are buying a majority stake in Medline Industries. Medline Industries is privately held, family-led health care firm that generated $17.5 billion in revenue in 2020.
The deal is valued around $34 billion, according to a Wall Street Journal report that cited people familiar with the matter. The transaction is expected to be completed in 2021.
After the deal, while the private equity group will own a majority stake in Medline, the Mills family will continue to be the largest shareholder in the company and will retain their leadership roles.
The Moving Average Convergence Divergence (MACD) for BX turned positive on March 21, 2024. Looking at past instances where BX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on March 20, 2024. You may want to consider a long position or call options on BX as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
BX moved above its 50-day moving average on March 20, 2024 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BX advanced for three days, in of 379 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 358 cases where BX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BX broke above its upper Bollinger Band on March 21, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. BX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BX's P/B Ratio (14.514) is slightly higher than the industry average of (3.028). P/E Ratio (71.397) is within average values for comparable stocks, (23.991). Projected Growth (PEG Ratio) (1.859) is also within normal values, averaging (3.116). Dividend Yield (0.025) settles around the average of (0.069) among similar stocks. P/S Ratio (14.164) is also within normal values, averaging (33.549).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment and fund management services
Industry InvestmentManagers